Skip to main content
logo
Entrada Therapeutics, Inc. (TRDA)
NASDAQ: TRDA · Real-Time Price · USD
7.67
+0.63 (8.95%)
Aug 12, 2026, 4:00 PM EDT - Market closed

Entrada Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-165.78-143.7565.63-6.69-94.62-51.16
Depreciation & Amortization
3.764.13.772.841.91.12
Stock-Based Compensation
19.3719.6117.9213.119.92.53
Other Adjustments
-2.37-3.67-10.02-5.780.150.07
Change in Receivables
0.362.52.2-5.88--
Changes in Accounts Payable
1.89-1.80.99-2.815.29-0.72
Changes in Accrued Expenses
1.214.741.713.811.763.96
Changes in Income Taxes Payable
--0.67-3.364.02--
Changes in Unearned Revenue
-0.71-19.83-119.81139.98--
Changes in Other Operating Activities
7.5910.25-0.58-2.81-18.16-6.67
Operating Cash Flow
-134.67-128.51-41.56139.8-93.79-50.86
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
0.32-1.04-3.16-5.61-2.89-4.58
Purchases of Investments
-60.79-141.61-437.72-407.21-221.98-
Proceeds from Sale of Investments
220.63259.46413.08274.4376.21-
Investing Cash Flow
160.16116.81-27.8-138.4-148.65-4.58

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
0.650.89102.9621.040.48191.63
Net Common Stock Issued (Repurchased)
0.650.89102.9621.040.48191.63
Issuance of Preferred Stock
-----115.83
Net Preferred Stock Issued (Repurchased)
-----115.83
Financing Cash Flow
0.650.89102.9621.040.48307.46

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
26.14-10.8233.6122.45-241.96252.02

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-134.35-129.55-44.72134.19-96.67-55.44
Free Cash Flow Growth
------
FCF Margin
-2867.07%-509.63%-21.21%104.01%--
Free Cash Flow Per Share
-3.22-3.13-1.154.06-3.09-8.85
Levered Free Cash Flow
-151.71-147.99-54.81132.74-106.72-58.04
Unlevered Free Cash Flow
-163.34-163.16-74.03131.34-109.35-58.01
SEC Filings: 10-K · 10-Q